Please log in to view this page
Username
Password
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
